Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 4Rhabdoid Tumor 3Pinealoma 3Neuroectodermal Tumors, Primitive 3Neoplasms, Germ Cell and Embryonal 3Medulloblastoma 3Lymphoma, Non-Hodgkin 3Lymphoma, Follicular 3Glioma 3Ependymoma 3Choroid Plexus Carcinoma 3Central Nervous System Neoplasms 3Brain Neoplasms 3Recurrence 2Lymphoma, Mantle-Cell 2Lymphoma, B-Cell, Marginal Zone 2Leukemia, Lymphocytic, Chronic, B-Cell 2Colorectal Neoplasms 2Burkitt Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms 1Nasopharyngeal Carcinoma 1Lymphoma, B-Cell 1Gliosarcoma 1Glioblastoma 1Diffuse Intrinsic Pontine Glioma 1Dendritic Cell Sarcoma, Interdigitating 1CD7-Positive Hematological Malignancies 1

Interventions

Cyclophosphamide 64fludarabine phosphate 37Peripheral Blood Stem Cell Transplantation 30Cyclosporine 30Radiotherapy 28Mycophenolic Acid 28Filgrastim 28Busulfan 28Whole-Body Irradiation 26Antilymphocyte Serum 24Melphalan 19Etoposide 19Tacrolimus 16Methotrexate 16Cord Blood Stem Cell Transplantation 16Methylprednisolone 15Rituximab 14Thiotepa 10Cytarabine 10Vincristine 8Prednisone 8Doxorubicin 8Carboplatin 7fludarabine 5Sirolimus 5sargramostim 4glofitamab 4aldesleukin 4Therapeutics 4Leucovorin 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Dendritic Cell Sarcoma, Interdigitating × Automobiles × Clear all
NCT05621096 2025-09-25

Low Dose Radiation as Bridging Therapy in Relapsed B-Cell Non-Hodgkin Lymphoma

University of Nebraska

Phase 1 Active not recruiting
33 enrolled
LymphoidSarcoma

Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡